Twist Bioscience Corporation

NasdaqGS:TWST 株式レポート

時価総額：US$2.8b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Twist Bioscience マネジメント

マネジメント 基準チェック /34

Twist Bioscience'sの CEO はEmily Leproustで、 Apr2013年に任命され、 の在任期間は 11.17年です。 の年間総報酬は$ 8.00Mで、 8.6%給与と91.4%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.37%を直接所有しており、その価値は$ 11.30M 。経営陣と取締役会の平均在任期間はそれぞれ3年と7.6年です。

主要情報

Emily Leproust

最高経営責任者

US$8.0m

報酬総額

CEO給与比率8.6%
CEO在任期間11.4yrs
CEOの所有権0.4%
経営陣の平均在職期間3.3yrs
取締役会の平均在任期間7.8yrs

経営陣の近況

Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

Jan 31
Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

Recent updates

Twist Bioscience (NASDAQ:TWST) Is In A Strong Position To Grow Its Business

Sep 25
Twist Bioscience (NASDAQ:TWST) Is In A Strong Position To Grow Its Business

Investors Aren't Buying Twist Bioscience Corporation's (NASDAQ:TWST) Revenues

Aug 20
Investors Aren't Buying Twist Bioscience Corporation's (NASDAQ:TWST) Revenues

Twist Bioscience: Lowered Biopharma Expectations Amid Financial Strain (Rating Downgrade)

Aug 04

Twist Bioscience: Growing Customer Base And Technology Platform Make Me Like This Stock

Jul 26

We Think Twist Bioscience (NASDAQ:TWST) Can Easily Afford To Drive Business Growth

Jun 10
We Think Twist Bioscience (NASDAQ:TWST) Can Easily Afford To Drive Business Growth

Twist Bioscience Corporation (NASDAQ:TWST) Shares Fly 29% But Investors Aren't Buying For Growth

May 04
Twist Bioscience Corporation (NASDAQ:TWST) Shares Fly 29% But Investors Aren't Buying For Growth

Twist Bioscience: NGS Is Taking Off

May 03

Twist Bioscience Corporation (NASDAQ:TWST) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Feb 27
Twist Bioscience Corporation (NASDAQ:TWST) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Twist Bioscience: Strong Performance In A Soft Market

Feb 07

Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

Jan 31
Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

We're Not Very Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn Rate

Jan 22
We're Not Very Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn Rate

Twist Bioscience Corporation's (NASDAQ:TWST) Price Is Right But Growth Is Lacking After Shares Rocket 44%

Dec 18
Twist Bioscience Corporation's (NASDAQ:TWST) Price Is Right But Growth Is Lacking After Shares Rocket 44%

Twist Bioscience (NASDAQ:TWST) Is In A Good Position To Deliver On Growth Plans

Oct 05
Twist Bioscience (NASDAQ:TWST) Is In A Good Position To Deliver On Growth Plans

We Think Twist Bioscience (NASDAQ:TWST) Can Afford To Drive Business Growth

Jul 07
We Think Twist Bioscience (NASDAQ:TWST) Can Afford To Drive Business Growth

Twist Biosciences collaborates with Enzolytics on monoclonal antibodies for viruses

Sep 16

Twist Bioscience: DNA Synthesis Leader Appealing 'Picks And Shovels' Play

Sep 02

CEO報酬分析

Twist Bioscience の収益と比較して、Emily Leproust の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$220m

Mar 31 2024n/an/a

-US$192m

Dec 31 2023n/an/a

-US$206m

Sep 30 2023US$8mUS$685k

-US$205m

Jun 30 2023n/an/a

-US$209m

Mar 31 2023n/an/a

-US$213m

Dec 31 2022n/an/a

-US$214m

Sep 30 2022US$6mUS$665k

-US$218m

Jun 30 2022n/an/a

-US$208m

Mar 31 2022n/an/a

-US$188m

Dec 31 2021n/an/a

-US$165m

Sep 30 2021US$1mUS$590k

-US$152m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$123m

Dec 31 2020n/an/a

-US$117m

Sep 30 2020US$7mUS$519k

-US$140m

Jun 30 2020n/an/a

-US$147m

Mar 31 2020n/an/a

-US$147m

Dec 31 2019n/an/a

-US$141m

Sep 30 2019US$8mUS$477k

-US$108m

Jun 30 2019n/an/a

-US$96m

Mar 31 2019n/an/a

-US$86m

Dec 31 2018n/an/a

-US$77m

Sep 30 2018US$525kUS$362k

-US$71m

Jun 30 2018n/an/a

-US$68m

Sep 30 2017US$2mUS$340k

-US$59m

報酬と市場: Emilyの 総報酬 ($USD 8.00M ) は、 US市場 ($USD 6.82M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Emilyの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Emily Leproust (51 yo)

11.4yrs

在職期間

US$7,998,637

報酬

Dr. Emily Marine Leproust, Ph.D. serves as Independent Director at CM Life Sciences, Inc. since September 2, 2020. She serves as an Independent Director at GeneDx Holdings Corp. (formerly known as Sema4 Ho...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Emily Leproust
Co-Founder11.4yrsUS$8.00m0.39%
$ 10.9m
Patrick Finn
President & COO1.9yrsUS$5.23m0.085%
$ 2.3m
Paula Green
Senior Vice President of Human Resources8.5yrsUS$2.49m0.039%
$ 1.1m
William Banyai
Senior VP of Advanced Development4.7yrsUS$2.82m0.44%
$ 12.2m
Adam Laponis
Chief Financial Officerless than a yearデータなし0.0029%
$ 81.4k
Robert Werner
VP & Chief Accounting Officer1.3yrsデータなし0.012%
$ 336.5k
Siyuan Chen
Chief Technology Officer3.6yrsデータなしデータなし
Aaron Sato
Chief Scientific Officer3.6yrsデータなしデータなし
Chet Gandhi
Chief Information Officer1.3yrsデータなしデータなし
Dennis Cho
Senior VP3yrsUS$1.96m0.050%
$ 1.4m
Angela Bitting
Chief ESG Officer & Senior VP of Corporate Affairs3.6yrsデータなしデータなし
Mark Buck
Senior Vice President of Operationsless than a yearデータなしデータなし

3.3yrs

平均在職期間

52yo

平均年齢

経験豊富な経営陣: TWSTの経営陣は 経験豊富 であると考えられます ( 3年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Emily Leproust
Co-Founder11.4yrsUS$8.00m0.39%
$ 10.9m
William Banyai
Senior VP of Advanced Development11.4yrsUS$2.82m0.44%
$ 12.2m
Keith Crandell
Independent Director10.9yrsUS$272.49k0.16%
$ 4.4m
Robert Chess
Lead Independent Director10.2yrsUS$303.98k0.11%
$ 3.0m
Nelson Chan
Independent Director5.3yrsUS$284.99k0.030%
$ 841.3k
Robert Ragusa
Independent Director7.8yrsUS$271.34k0.023%
$ 640.5k
Jan Johannessen
Independent Director5.9yrsUS$284.99k0.020%
$ 547.0k
Melissa Starovasnik
Independent Director3.1yrsUS$276.61k0.019%
$ 512.5k
Xiaoying Mai
Independent Director6.2yrsUS$269.99k0.043%
$ 1.2m

7.8yrs

平均在職期間

64yo

平均年齢

経験豊富なボード: TWSTの 取締役会 は 経験豊富 であると考えられます ( 7.6年の平均在任期間)。